Patents by Inventor Junji Takaba

Junji Takaba has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8993536
    Abstract: A low-molecular-weight polysulfated hyaluronic acid derivative useful for treatment of an allergic disease. An agent for treatment of an allergic disease selected from pollinosis, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, and asthma, represented by the following general formula (IA) or (IB); wherein n represents a number of 0 to 15; R's each independently represent a hydrogen atom or an SO3H group etc.
    Type: Grant
    Filed: February 1, 2010
    Date of Patent: March 31, 2015
    Assignees: Otsuka Chemical Co., Ltd., Otsuka Pharmaceutical Co., Ltd.
    Inventors: Kazuaki Kakehi, Hiroaki Asai, Naohiro Hayashi, Satoshi Shimizu, Fumitaka Goto, Yasuo Koga, Takahiro Tomoyasu, Takao Taki, Yusuke Kato, Satoru Nakazato, Junji Takaba, Atsushi Azuma, Wakako Hirano, Kazunari Izumi, Minoru Kashimoto, Yoko Sakamoto, Takashi Hayashi, Masaru Nishida
  • Patent number: 8926543
    Abstract: The invention provides a way of producing a natural immunologically active state in a person by subjecting him to an apheresis procedure with bioincompatible biomaterials for about one hour. To safely control the immunological shock induced by this procedure, the person is put under general anesthesia for about six hours, including the apheresis time and at least an additional five hours thereafter. This immunological activation is useful for treating malignant tumors and diseases related to immunosuppression, such as AIDS. The invention also provides for the use of an apheresis column containing a blood perfusion filter with bioincompatible materials for treating malignant tumors and infectious diseases.
    Type: Grant
    Filed: October 7, 2010
    Date of Patent: January 6, 2015
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Kazuhide Ohta, Hiroshi Miyamoto, Junji Takaba, Ako Nosé
  • Publication number: 20130046225
    Abstract: The invention provides a way of producing a natural immunologically active state in a person by subjecting him to an apheresis procedure with bioincompatible biomaterials for about one hour. To safely control the immunological shock induced by this procedure, the person is put under general anesthesia for about six hours, including the apheresis time and at least an additional five hours thereafter. This immunological activation is useful for treating malignant tumors and diseases related to immunosuppression, such as AIDS. The invention also provides for the use of an apheresis column containing a blood perfusion filter with bioincompatible materials for treating malignant tumors and infectious diseases.
    Type: Application
    Filed: October 7, 2010
    Publication date: February 21, 2013
    Inventors: Kazuhide Ohta, Hiroshi Miyamoto, Junji Takaba, Ako Nose
  • Publication number: 20110281819
    Abstract: A low-molecular-weight polysulfated hyaluronic acid derivative useful for prevention and/or treatment of an allergic disease. An agent for prevention and/or treatment of an allergic disease selected from pollinosis, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, and asthma, represented by the following general formula (IA) or (IB); wherein n represents a number of 0 to 15; R?s each independently represent a hydrogen atom or an SO3H group etc.
    Type: Application
    Filed: February 1, 2010
    Publication date: November 17, 2011
    Applicants: OTSUKA PHARMACEUTICAL CO., LTD., OTSUKA CHEMICAL CO., LTD.
    Inventors: Kazuaki Kakehi, Hiroaki Asai, Naohiro Hayashi, Satoshi Shimizu, Fumitaka Goto, Yasuo Koga, Takahiro Tomoyasu, Takao Taki, Yusuke Kato, Satoru Nakazato, Junji Takaba, Atsushi Azuma, Wakako Hirano, Kazunari Izumi, Minoru Kashimoto, Yoko Sakamoto, Takashi Hayashi, Masaru Nishida